✦ LIBER ✦

Chronic cough associated with interferon/ribavirin therapy for hepatitis C

✍ Scribed by P. V. Dicpinigaitis; F. R. Weiner

Book ID: 108849379
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 111 KB
Volume: 36
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2010.01182.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-ribavirin combination therapy

Interferon-ribavirin combination therapy for chronic hepatitis C

✍ Solko W. Schalm; J. T. Brouwer; L. Chemello; A. Alberti; A. Bellobuono; G. Ideo; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 466 KB

Continued ribavirin monotherapy followin

Continued ribavirin monotherapy following interferon–ribavirin combination therapy is not effective for chronic hepatitis C

✍ Shinichi Kakumu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Pleural effusion associated with pegylat

Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C

✍ Amit Arora; Leonardo Vargas; Tomasz J. Kuzniar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following

Pegylated interferon and ribavirin thera

Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection

✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Sauné; J.P. Vinel; L. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Treatment of chronic hepatitis C with PE

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 513 KB